Research from the Babraham Institute has developed a method to ‘time jump’ human skin cells by 30 years, turning back the ageing clock for cells without losing their specialised function. Work by researchers in the Institute’s Epigenetics research programme has been able to partly restore the function of older cells, as well as rejuvenating the molecular measures of biological age. The research is published today in the journal eLife and whilst at an early stage of exploration, it could revolutionise regenerative medicine.
What
is regenerative medicine?
As we age, our cells’ ability to
function declines and the genome accumulates marks of ageing. Regenerative
biology aims to repair or replace cells including old ones. One of the most
important tools in regenerative biology is our ability to create ‘induced’ stem
cells. The process is a result of several steps, each erasing some of the marks
that make cells specialised. In theory, these stem cells have the potential to
become any cell type, but scientists aren’t yet able to reliably recreate the
conditions to re-differentiate stem cells into all cell types.
Turning
back time
The new method, based on the Nobel Prize
winning technique scientists use to make stem cells, overcomes the problem of
entirely erasing cell identity by halting reprogramming part of the way through
the process. This allowed researchers to find the precise balance between
reprogramming cells, making them biologically younger, while still being able
to regain their specialised cell function.
In 2007, Shinya Yamanaka was the first
scientist to turn normal cells, which have a specific function, into stem cells
which have the special ability to develop into any cell type. The full process
of stem cell reprogramming takes around 50 days using four key molecules called
the Yamanaka factors. The new method, called ‘maturation phase transient
reprogramming’, exposes cells to Yamanaka factors for just 13 days. At this
point, age-related changes are removed and the cells have temporarily lost
their identity. The partly reprogrammed cells were given time to grow under
normal conditions, to observe whether their specific skin cell function
returned. Genome analysis showed that cells had regained markers characteristic
of skin cells (fibroblasts), and this was confirmed by observing collagen
production in the reprogrammed cells.
Age
isn’t just a number
To show that the cells had been
rejuvenated, the researchers looked for changes in the hallmarks of ageing. As
explained by Dr Diljeet Gill, a postdoc in Wolf Reik’s lab at the Institute who
conducted the work as a PhD student: “Our understanding of ageing on a
molecular level has progressed over the last decade, giving rise to techniques
that allow researchers to measure age-related biological changes in human
cells. We were able to apply this to our experiment to determine the extent of
reprogramming our new method achieved.”
Researchers looked at multiple measures
of cellular age. The first is the epigenetic clock, where chemical tags present
throughout the genome indicate age. The second is the transcriptome, all the
gene readouts produced by the cell. By these two measures, the reprogrammed
cells matched the profile of cells that were 30 years younger compared to
reference data sets.
The potential applications of this
technique are dependent on the cells not only appearing younger, but
functioning like young cells too. Fibroblasts produce collagen, a molecule
found in bones, skin tendons and ligaments, helping provide structure to
tissues and heal wounds. The rejuvenated fibroblasts produced more collagen
proteins compared to control cells that did not undergo the reprogramming
process. Fibroblasts also move into areas that need repairing. Researchers
tested the partially rejuvenated cells by creating an artificial cut in a layer
of cells in a dish. They found that their treated fibroblasts moved into the
gap faster than older cells. This is a promising sign that one day this
research could eventually be used to create cells that are better at healing
wounds.
In the future, this research may also
open up other therapeutic possibilities; the researchers observed that their
method also had an effect on other genes linked to age-related diseases and
symptoms. The APBA2 gene, associated with Alzheimer’s disease,
and the MAF gene
with a role in the development of cataracts, both showed changes towards
youthful levels of transcription.
The mechanism behind the successful
transient reprogramming is not yet fully understood, and is the next piece of
the puzzle to explore. The researchers speculate that key areas of the genome
involved in shaping cell identity might escape the reprogramming process.
Diljeet concluded: “Our results
represent a big step forward in our understanding of cell reprogramming. We
have proved that cells can be rejuvenated without losing their function and
that rejuvenation looks to restore some function to old cells. The fact that we
also saw a reverse of ageing indicators in genes associated with diseases is
particularly promising for the future of this work.”
Professor Wolf Reik, a group leader in
the Epigenetics research programme who has recently moved to lead the Altos
Labs Cambridge Institute, said: “This work has very exciting implications.
Eventually, we may be able to identify genes that rejuvenate without
reprogramming, and specifically target those to reduce the effects of ageing.
This approach holds promise for valuable discoveries that could open up an
amazing therapeutic horizon.”
Source: https://www.babraham.ac.uk/news/2022/04/new-technique-rewinds-age-skin-cells-30-years
Journal article: https://elifesciences.org/articles/71624
Source: Old
skins cells reprogrammed to regain youthful function – Scents of Science
(myfusimotors.com)
No comments:
Post a Comment